ロード中...
Development of a novel patient-reported measure for acromegaly: the Acro-TSQ
PURPOSE: Somatostatin analogs (SSAs) represent a mainstay of medical treatment for acromegaly, currently available as either intramuscular or deep subcutaneous injections. Patient-reported outcomes (PROs) are increasingly common as relevant outcomes in studies of acromegaly and its treatment, but th...
保存先:
| 出版年: | Pituitary |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6842345/ https://ncbi.nlm.nih.gov/pubmed/31522359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11102-019-00986-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|